Exactly!! There was an article published 10 March
Post# of 148192
"They also announced their intentions to proceed with eight phase 2 clinical trials in cancer after they complete their preclinical studies which is a feat that only eight $100 billion dollar drug companies have ever accomplished. "
https://emerginggrowth.com/bio-path-nasdaq-bp...-analysis/
We just need to get positive clinical results for cancer and get a little valuation in the share price.